FMP
Nov 12, 2025(Last modified: Nov 13, 2025)
Brown & Brown, Inc. (NYSE:BRO) is a prominent player in the insurance brokerage industry, providing a wide range of insurance products and services. The company operates in a competitive landscape alongside peers like Arthur J. Gallagher & Co. (AJG) and W. R. Berkley Corporation (WRB). A key metric for evaluating these companies is the comparison between Return on Invested Capital (ROIC) and Weighted Average Cost of Capital (WACC).
Brown & Brown's ROIC is 4.89%, which is lower than its WACC of 7.00%. This results in a ROIC to WACC ratio of 0.70, indicating that the company is not generating returns that exceed its cost of capital. This suggests that Brown & Brown may need to reassess its capital allocation strategies to improve its financial performance.
In comparison, Arthur J. Gallagher & Co. has a ROIC of 5.29% and a WACC of 6.24%, resulting in a ROIC to WACC ratio of 0.85. While AJG's ratio is higher than BRO's, it still falls short of generating returns that surpass its cost of capital. This highlights the challenges faced by companies in the insurance brokerage sector in achieving efficient capital utilization.
On the other hand, W. R. Berkley Corporation stands out with a remarkable ROIC of 55.96% against a WACC of 5.35%, yielding a ROIC to WACC ratio of 10.46. This indicates that WRB is highly effective in generating returns on its invested capital, significantly exceeding its cost of capital. Such performance underscores the importance of strategic capital management in achieving superior financial outcomes.
RenaissanceRe Holdings Ltd. (RNR) is the most efficient among the peers, with an impressive ROIC of 131.46% and a WACC of 4.79%, resulting in a ROIC to WACC ratio of 27.47. This exceptional ratio highlights RNR's ability to generate substantial returns on its invested capital, setting a benchmark for capital efficiency in the industry.
TriSalus Life Sciences Inc. (NASDAQ: TLSI) is a company that focuses on oncology, specifically integrating novel deliver...
Sanara MedTech Inc. (NASDAQ: SMTI) is a company focused on medical technology, aiming to improve clinical outcomes and r...